These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 21478190)

  • 21. [Practice guidelines for patients with rheumatoid arthritis].
    Fang LK; Huang CH; Xie Y; Liu Q; Wang XQ; He DY; Liu Y; Zhou YQ; Wang K; Li YJ; Xian XM; Cao SY; Zeng XF; Yang KH; Gu JR
    Zhonghua Nei Ke Za Zhi; 2020 Oct; 59(10):772-780. PubMed ID: 32987479
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Treatment strategies are more important than drugs in the management of rheumatoid arthritis.
    Drosos AA; Pelechas E; Voulgari PV
    Clin Rheumatol; 2020 Apr; 39(4):1363-1368. PubMed ID: 32088801
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Determining the acceptable level of physician compliance with a treat-to-target strategy in early rheumatoid arthritis.
    Wabe N; Sorich MJ; Wechalekar MD; Cleland LG; McWilliams L; Lee A; Spargo L; Metcalf R; Hall C; Proudman SM; Wiese MD
    Int J Rheum Dis; 2017 May; 20(5):576-583. PubMed ID: 26692459
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Adjustment in the clinical practice of treat-to-target guidelines for rheumatoid arthritis: Results of the ToARCan study.
    Naranjo A; Cáceres L; Hernández-Beriaín JÁ; Francisco F; Ojeda S; Talaverano S; Nóvoa-Medina J; Martín JA; Delgado E; Trujillo E; Álvarez F; Magdalena L; Rodríguez-Lozano C
    Reumatol Clin; 2016; 12(1):34-8. PubMed ID: 25869900
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Characterising deviation from treat-to-target strategies for early rheumatoid arthritis: the first three years.
    Wabe N; Sorich MJ; Wechalekar MD; Cleland LG; McWilliams L; Lee A; Spargo L; Metcalf RG; Hall C; Proudman SM; Wiese MD
    Arthritis Res Ther; 2015 Mar; 17(1):48. PubMed ID: 25889527
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Implementation of the treat-to-target approach and treatment satisfaction in patients with rheumatoid arthritis: perspectives of Chinese rheumatologists.
    Zhao JL; Liu X; Nan Li J; Ru Liu M; Rottier E; Zhao Y; Zeng XF
    Clin Rheumatol; 2022 Sep; 41(9):2659-2668. PubMed ID: 35579773
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Kuwait association of rheumatology 2018 treatment recommendations for patients with rheumatoid arthritis.
    Alhajeri H; Abutiban F; Al-Adsani W; Al-Awadhi A; Aldei A; AlEnizi A; Alhadhood N; Al-Herz A; Alkandari W; Dehrab A; Muhanna Ghanem AA; Hasan E; Hayat S; Saleh K; Tarakmeh H; Ali Y
    Rheumatol Int; 2019 Sep; 39(9):1483-1497. PubMed ID: 31309293
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Treating rheumatoid arthritis to target: a Canadian physician survey.
    Haraoui B; Bensen W; Bessette L; Le Clercq S; Thorne C; Wade J
    J Rheumatol; 2012 May; 39(5):949-53. PubMed ID: 22467920
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Optimal treatment of rheumatoid arthritis: EULAR recommendations for clinical practice.
    Bijlsma JW
    Pol Arch Med Wewn; 2010 Sep; 120(9):347-53. PubMed ID: 20864908
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effectiveness and safety of treat-to-target strategy in elderly-onset rheumatoid arthritis: a 3-year prospective observational study.
    Sugihara T; Ishizaki T; Onoguchi W; Baba H; Matsumoto T; Iga S; Kubo K; Kamiya M; Hirano F; Hosoya T; Miyasaka N; Harigai M
    Rheumatology (Oxford); 2021 Sep; 60(9):4252-4261. PubMed ID: 33410490
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Recent Advances in Nanotheranostics for Treat-to-Target of Rheumatoid Arthritis.
    Wang S; Lv J; Meng S; Tang J; Nie L
    Adv Healthc Mater; 2020 Mar; 9(6):e1901541. PubMed ID: 32031759
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Benefits and Sustainability of a Learning Collaborative for Implementation of Treat-to-Target in Rheumatoid Arthritis: Results of a Cluster-Randomized Controlled Phase II Clinical Trial.
    Solomon DH; Lu B; Yu Z; Corrigan C; Harrold LR; Smolen JS; Fraenkel L; Katz JN; Losina E
    Arthritis Care Res (Hoboken); 2018 Oct; 70(10):1551-1556. PubMed ID: 29316341
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Treating to target in established rheumatoid arthritis: Challenges and opportunities in an era of novel targeted therapies and biosimilars.
    Woodworth TG; den Broeder AA
    Best Pract Res Clin Rheumatol; 2015; 29(4-5):543-9. PubMed ID: 26697765
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Monitoring patients with rheumatoid arthritis in routine care: experiences from a treat-to-target strategy using the DANBIO registry.
    Hetland ML; Jensen DV; Krogh NS
    Clin Exp Rheumatol; 2014; 32(5 Suppl 85):S-141-6. PubMed ID: 25365104
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Long-term outcomes of treat-to-target strategy in established rheumatoid arthritis: a daily practice prospective cohort study.
    de Andrade NPB; da Silva Chakr RM; Xavier RM; Viecceli D; Correa RHB; de Oliveira Filho CM; Brenol CV
    Rheumatol Int; 2017 Jun; 37(6):993-997. PubMed ID: 28293776
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Treat to target strategy in early rheumatoid arthritis versus routine care - A comparative clinical practice study.
    Brinkmann GH; Norvang V; Norli ES; Grøvle L; Haugen AJ; Lexberg ÅS; Rødevand E; Bakland G; Nygaard H; Krøll F; Widding-Hansen IJ; Bjørneboe O; Thunem C; Kvien T; Mjaavatten MD; Lie E
    Semin Arthritis Rheum; 2019 Apr; 48(5):808-814. PubMed ID: 30205983
    [TBL] [Abstract][Full Text] [Related]  

  • 37. ASAS/EULAR recommendations for the management of ankylosing spondylitis: the patient version.
    Kiltz U; van der Heijde D; Mielants H; Feldtkeller E; Braun J;
    Ann Rheum Dis; 2009 Sep; 68(9):1381-6. PubMed ID: 18930993
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Paradigm shift and future perspectives in rheumatoid arthritis].
    Miyasaka N
    Nihon Rinsho; 2013 Jul; 71(7):1141-6. PubMed ID: 23961658
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Rheumatoid arthritis: 2014 treat-to-target RA recommendations--strategy is key.
    Huizinga T; Knevel R
    Nat Rev Rheumatol; 2015 Sep; 11(9):509-11. PubMed ID: 26195337
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Comorbidities-Their role in the treat to target concept for rheumatoid arthritis].
    Krüger K; Kneitz C
    Z Rheumatol; 2019 Jun; 78(5):422-428. PubMed ID: 31049664
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.